Skip to content

AIM round-up: Rua Life Sciences, Oriole Resources, Bradda Head Lithium


The AIM Index started its last full trading week of the year picking up yet more losses, shedding another two points with all eyes squarely on the Fed’s rate verdict that is due on Wednesday. At the bell, the junior market sat at 831.73

  • Rua Life Sciences +35%
  • Oriole Resources +32%
  • Bradda Head Lithium +21%
  • Engage XR Holdings -48%
  • Capital Metals -42%

Interims from Rua Life Sciences LON:RUA served the stock well, which had added 35% by the close. The share price has however been under pressure for the last few months so even though there was nothing revolutionary in the note, the uptick in revenues and reduction in losses was well received.

Oriole Resources LON:ORR advanced 32% by the bell. The company made two announcements this morning but it was the pre-open statement about likely metals deposits in a Cameroon project that ignited support. Gains do however need to be put in context of the 15% spread that was being quoted just ahead of the close

Bradda Head Lithium LON:BHL gets the notable mention, up 21% on the day. Sustained demand for Lithium along with expectations that assay results are imminent appears to be driving demand for the stock with notably elevated levels of trade being recorded on the day.

Engage XR [LON:EXR] was 48% lower at the close, with the stock rattled by this morning’s trading update. Despite strong revenue growth, the company notes a slowing of the sales cycle, suggesting that big firms are being more diligent in terms of procurement – especially when it comes to the metaverse space. The shares now trade back at levels not seen since the start of 2020, back when the company was focused on VR.

Capital Metals LON:CMET slipped 42% in the wake of a notification from the Sri Lankan authorities that licenses have been suspended whilst they seek approvals for ownership structures in the country. The company is seeking to engage and resolve these matters quickly but clearly they are disruptive.

Looking for great investing ideas? Sign up to our free newsletter.

This article does not constitute investment advice. Make sure you do your own research or consult a professional advisor.

'How to' Guides

Our latest in-depth company reports

Detailed reviews of selected companies and investment trusts.

On the podcast

Sign up for great investing stock tips

Thanks to our Site Partners

Our partners are established, regulated businesses and we are grateful for their support.

CME Group
FP Markets
Back To Top